Cardiovascular side-effects of modern cancer therapy

Manabu Minami, Shigemi Matsumoto, Hisanori Horiuchi

Research output: Contribution to journalReview articlepeer-review

64 Citations (Scopus)


Recent advances in chemotherapy have substantially improved the prognosis of cancer patients. However, many anticancer drugs, especially newly developed 'molecular-target drugs', such as the anti-HER2 blocking antibody and the anti-vascular endothelial growth factor antibody, have serious cardiovascular side-effects such as heart failure, thromboembolism, severe hypertension and lethal arrhythmia, which interrupt cancer treatment and decrease the patient's quality of life. Despite the increasing clinical significance, cardiologists have not been focusing enough of their attention on this issue. The major cardiovascular complications associated with anticancer drugs, and current diagnosis, treatment and prevention strategies are reviewed. Close collaborations between oncologists and cardiologists is necessary to tackle cardiovascular complications and advance cancer treatment.

Original languageEnglish
Pages (from-to)1779-1786
Number of pages8
JournalCirculation Journal
Issue number9
Publication statusPublished - 2010


  • Cancer
  • Cardioncology
  • Cardiotoxicity
  • Chemotherapy


Dive into the research topics of 'Cardiovascular side-effects of modern cancer therapy'. Together they form a unique fingerprint.

Cite this